I don't see why that's a contradiction. Much of human development has been based around people discussing things in order to collectively reach more accurate conclusions.
If you think you've already got all the answers, why are you even here?
- Forums
- ASX - By Stock
- AVR
- FY19 $1.25 target
FY19 $1.25 target, page-26
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.93 |
Change
-0.070(0.39%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $56.90K | 3.182K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 124 | $17.93 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.95 | 289 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 691 | 17.900 |
1 | 1 | 17.800 |
1 | 26 | 17.740 |
1 | 443 | 17.700 |
1 | 26 | 17.650 |
Price($) | Vol. | No. |
---|---|---|
17.910 | 43 | 3 |
17.930 | 31 | 2 |
17.950 | 289 | 3 |
18.000 | 300 | 1 |
18.250 | 100 | 1 |
Last trade - 15.32pm 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online